Meet the Team

arron, david, jane, pedro and ryan from kinomica

Our shared vision and passion for helping patients affected by serious disease, and our unparalleled scientific expertise propels everything we do.
Meet Kinomica’s highly experienced and dynamic team with multidisciplinary expertise across the fields of cell signalling, proteomics and advanced bioinformatics…

Our Team

Jane Theaker, Chief Executive Officer

Jane Theaker

CEO

Anthony Sullivan, Director of Business Development

Tony Sullivan

Business Development Director

Mondana Cook, Chief Operating Officer

Mondana Cook

Chief Operating Officer

Pedro R. Cutillas, Professor of Cell Signalling & Proteomics

Pedro Cutillas

co-Founder & Consultant

Arran Dokal, Head of Development

Arran Dokal

Senior Scientist

David Britton, Chief Scientific Officer & Co-founder at Kinomica

David Britton

co-Founder & Head of Research

Our Investors

Rebecca Todd, Investment Director

Rebecca Todd

Investor - Longwall

Claire Brown, Investor and Board Member at Kinomica

Claire Brown

Investor - Biocity

Rhys Davenport, Investment Partner

Rhys Davenport

Investor - BGF

black plastic computer keyboard on a black desk

Kinomica News

Learn more about Kinomica, our team and our technology through our in-depth blog content. We’ll also let you know what events we are attending as well

Talk to our Experts

To find out more about the technology behind Kinomica’s advanced bioinformatics and phosphoproteomics analytical methods, talk to our experts.

Contact Us

If you have any questions or need any further information, then please contact the Kinomica team – we are more than happy to help.

“Our groundbreaking technology driven by deep expertise and powerful insights provides a direct snapshot of protein and cell-signalling activity, with data that demonstrates we can predict drug response far more accurately than current gene mutation markers”

Anthony Sullivan, Business Development Director